home / stock / howl / howl quote
Last: | $3.01 |
---|---|
Change Percent: | -0.62% |
Open: | $3.27 |
Close: | $3.01 |
High: | $3.27 |
Low: | $3.01 |
Volume: | 193,527 |
Last Trade Date Time: | 06/14/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.01 | $3.27 | $3.01 | $3.27 | $3.01 | 193,527 | 06-14-2024 |
$3.25 | $3.15 | $3.25 | $3.49 | $3.135 | 294,835 | 06-13-2024 |
$3.07 | $3.21 | $3.07 | $3.46 | $2.95 | 368,920 | 06-12-2024 |
$3.2 | $3.27 | $3.2 | $3.34 | $3.02 | 171,294 | 06-11-2024 |
$3.25 | $3.18 | $3.25 | $3.47 | $3.06 | 312,672 | 06-10-2024 |
$3.49 | $3.49 | $3.49 | $3.695 | $3.3606 | 172,619 | 06-07-2024 |
$3.5 | $3.59 | $3.5 | $3.645 | $3.35 | 260,315 | 06-06-2024 |
$3.59 | $3.64 | $3.59 | $3.715 | $3.42 | 187,000 | 06-05-2024 |
$3.64 | $4.16 | $3.64 | $4.16 | $3.59 | 297,651 | 06-04-2024 |
$3.99 | $4.73 | $3.99 | $4.73 | $3.89 | 417,262 | 06-03-2024 |
$5.17 | $5.38 | $5.17 | $5.73 | $5.08 | 311,879 | 05-31-2024 |
$5.36 | $5.04 | $5.36 | $5.47 | $4.97 | 110,270 | 05-30-2024 |
$5.09 | $4.87 | $5.09 | $5.21 | $4.87 | 73,390 | 05-29-2024 |
$4.96 | $4.91 | $4.96 | $5.19 | $4.665 | 225,536 | 05-28-2024 |
$4.88 | $5.1 | $4.88 | $5.56 | $4.84 | 220,666 | 05-27-2024 |
$4.88 | $5.1 | $4.88 | $5.56 | $4.84 | 220,666 | 05-24-2024 |
$5.16 | $4.89 | $5.16 | $5.16 | $4.8239 | 130,707 | 05-23-2024 |
$4.89 | $5.19 | $4.89 | $5.19 | $4.75 | 175,269 | 05-22-2024 |
$5 | $4.77 | $5 | $5.29 | $4.765 | 81,368 | 05-21-2024 |
$4.78 | $4.69 | $4.78 | $4.93 | $4.57 | 343,417 | 05-20-2024 |
News, Short Squeeze, Breakout and More Instantly...
Werewolf Therapeutics Inc. Company Name:
HOWL Stock Symbol:
NASDAQ Market:
- WTX-124 was shown to be clinically active and generally well-tolerated in patients who were relapsed/refractory to immune checkpoint inhibitor...
- WTX-124 was shown to be clinically active and generally well-tolerated in patients who were relapsed/refractory to immune checkpoint inhibitor therapy - - Encouraging single agent clinical activity with three objective responses, including a durable confirmed complete respon...
WATERTOWN, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the "Company" or "Werewolf") (NASDAQ:HOWL), an innovative biopha...